Integrating New Skills Into Diabetes Education With CGM

This study is looking at different ways to teach older adults (65 and older) who use insulin how to get the most out of their continuous glucose monitor (CGM). It compares a new three-stage training program to two standard approaches: a one-time clinic training or self-guided learning. The goal is to see if the new program helps people wear their CGM more often, better manage their blood sugar, and improve their overall experience. You would need to be receiving care at a UNC Health or UNC Physicians Network clinic. The study plans to enroll 144 participants, but its current recruitment status is unclear.

Study design: This is an interventional study that will randomly assign 144 participants to one of three groups to compare different CGM training methods.
What's involved: Participants will be randomized to one of three groups for 6 weeks. The intervention group attends three educational sessions over 4 weeks (one in-person, two virtual).
Compensation: Not stated in the trial record.
Follow-up: The primary endpoint, CGM Wear Time, is measured over 6 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Integrating New Skills Into Diabetes Education With CGM

Recruiting

NAAges 65+InterventionalTreatment

University of North Carolina, Chapel Hill

~144 participants

Updated 2026-08-14 on ClinicalTrials.gov

What's tested:Three-stage CGM integration programOne-time clinic-based CGM trainingSelf-directed CGM training

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

CGM Wear Time

Measured over Over 6 Weeks

Conditions

Insulin Dependent Diabetes

Diabetes (DM)

Diabetes (Insulin-requiring, Type 1 or Type 2)

Diabetes Education

Diabetes Care

Type 1 Diabetes (T1D)

Type 2 Diabetes Mellitus (T2DM)

Where it's being run

1 sites across 1 states

North Carolina1

Study leadership

Anna Kahkoska, MD, PhD · PRINCIPAL_INVESTIGATOR · University of North Carolina, Chapel Hill

Who to contact

Marcy Menard, MS, RD, LDN, CDCES

[email protected]

919-843-9977

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Adults 65 years and older at time of consent

Actively receiving care at a UNC Health or UNC Physicians Network clinic (defined as 2 or more visits in primary care, family medicine, internal medicine, geriatrics, or endocrinology clinics within the past 365 days). Locality for care is defined as receiving care within a 90-mile radius of UNC Main Hospital on Manning Drive in Chapel Hill, NC.

Using any insulin at least once daily

No continuous glucose monitor (CGM) use within the previous 365 days

Willing to use a smartphone to access glucose readings using CGM phone app

Fluent in English

Live in the same household as the study participant

Age 18 years or older

Fluent in English

Be willing to attend sessions alongside the study participant and learn how they can better support their partner participant to manage diabetes

Consent to recording of sessions

Exclusion

Clinical diagnosis of dementia, assessed through chart review and self-report on screening visit (cognitive impairment that is mild and not considered sufficient for diagnosis of dementia is acceptable)

Currently receiving dialysis, assessed through chart review and self-report on screening visit

Extreme visual or hearing impairment that would impair ability to use real-time CGM or attend and participate in an in-person or virtual group intervention session, assessed at screening visit

The presence of a significant medical or psychiatric condition or use of a medication that in the judgment of the investigator may affect completion of any aspect of the protocol, or is likely to be associated with life expectancy of \<1 year, assessed at screening visit

Unavailable for 6-week study duration (such as planned surgery or procedure, planned vacation, etc.) or unwilling to comply with study procedures

Not fluent in English

Unable to consent to recording of sessions

What this trial measures

CGM Wear TimeOver 6 Weeks
CGM wear time will be calculated as the percentage of time that the sensor is in use and providing data, relative to the total time it could have been worn, with a total of 6-weeks of total possible wear during the active intervention period.

Trialytics